{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:07:24Z","timestamp":1780445244170,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT N\u00ba: 2014-1566"],"award-info":[{"award-number":["PICT N\u00ba: 2014-1566"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PID N\u00ba 1122015 0100753"],"award-info":[{"award-number":["PID N\u00ba 1122015 0100753"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006449","name":"Fundaci\u00f3n Alberto J. Roemmers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00428-025-04047-z","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T13:51:42Z","timestamp":1740059502000},"page":"1039-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PD-L1\/PD-L2 genetic profile in the molecular cytogenetic classification of classic Hodgkin lymphoma"],"prefix":"10.1007","volume":"486","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4548-6664","authenticated-orcid":false,"given":"Mauro","family":"Garc\u00eda-Montenegro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Narbaitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Fernanda","family":"Metrebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Pavlovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Slavutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"1","key":"4047_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrc2542","volume":"9","author":"R Kuppers","year":"2009","unstructured":"Kuppers R (2009) The biology of Hodgkin\u2019s lymphoma. Nat Rev Cancer 9(1):15\u201327. https:\/\/doi.org\/10.1038\/nrc2542","journal-title":"Nat Rev Cancer"},{"key":"4047_CR2","unstructured":"Borges AM, Delabie J, Vielh F, et al (2024) Classic Hodgkin lymphoma. In: WHO classification of tumours editorial board, haematolymphoid tumours,\u00a0Lyon (France). WHO classification of tumours series, 5th edn, vol 11. International Agency for Research on Cancer.\u00a0https:\/\/publications.iarc.who.int\/637"},{"issue":"4","key":"4047_CR3","first-page":"298","volume":"84","author":"D Falzetti","year":"1999","unstructured":"Falzetti D, Crescenzi B, Matteuci C et al (1999) Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin\u2019s disease. Haematologica 84(4):298\u2013305","journal-title":"Haematologica"},{"key":"4047_CR4","doi-asserted-by":"publisher","unstructured":"Cuceu C, Hempel WM, Sabatier L, Bosq J, Carde P, M'kacher R (2018) Chromosomal instability in Hodgkin lymphoma: an in-depth review and perspectives. Cancers 10(4):91.\u00a0https:\/\/doi.org\/10.3390\/cancers10040091","DOI":"10.3390\/cancers10040091"},{"issue":"4","key":"4047_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1593\/tlo.12142","volume":"5","author":"H Knecht","year":"2012","unstructured":"Knecht H, Kongruttanachok N, Sawan B et al (2012) Three-dimensional telomere signatures of Hodgkin- and Reed-Sternberg cells at diagnosis identify patients with poor response to conventional chemotherapy. Transl Oncol 5(4):269\u2013277. https:\/\/doi.org\/10.1593\/tlo.12142","journal-title":"Transl Oncol"},{"issue":"2","key":"4047_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/(SICI)1096-9896(199806)185:2<145::AID-PATH82>3.0.CO;2-F","volume":"185","author":"MP Jansen","year":"1998","unstructured":"Jansen MP, Hopman AH, Haesevoets AM et al (1998) Chromosomal abnormalities in Hodgkin\u2019s disease are not restricted to Hodgkin\/Reed-Sternberg cells. J Pathol 185(2):145\u2013152. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199806)185:2%3c145::AID-PATH82%3e3.0.CO;2-F","journal-title":"J Pathol"},{"key":"4047_CR7","doi-asserted-by":"publisher","unstructured":"Barrios L, Caballin MR, Miro R et al (1988) Chromosome abnormalities in peripheral blood lymphocytes from untreated Hodgkin\u2019s patients. a possible evidence for chromosome instability. Hum Genet 78(4):320\u2013324. https:\/\/doi.org\/10.1007\/BF00291727","DOI":"10.1007\/BF00291727"},{"issue":"2","key":"4047_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s0360-3016(03)00578-9","volume":"57","author":"R M\u2019Kacher","year":"2003","unstructured":"M\u2019Kacher R, Girinsky T, Koscielny S et al (2003) Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin\u2019s lymphoma patients. Int J Radiat Oncol Biol Phys 57(2):321\u2013326. https:\/\/doi.org\/10.1016\/s0360-3016(03)00578-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"4047_CR9","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.3390\/ijms20215503","volume":"20","author":"E Calabretta","year":"2019","unstructured":"Calabretta E, D\u2019Amore F, Carlo-Stella S (2019) Immune and inflammatory cells of the tumor microenvironment represent novel therapeutic targets in classical Hodgkin lymphoma. Int J Mol Sci 20(21):5503. https:\/\/doi.org\/10.3390\/ijms20215503","journal-title":"Int J Mol Sci"},{"key":"4047_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"M Keir","year":"2008","unstructured":"Keir M, Butte M, Freeman G, Sharpe AH (2008) PD-1 and its ligand in tolerance and immunity. Annu Rev Immunol 26:677\u2013704. https:\/\/doi.org\/10.1146\/annurev.immunol.26.021607.090331","journal-title":"Annu Rev Immunol"},{"issue":"13","key":"4047_CR11","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco LM, Salinas VH, Brown KE et al (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206(13):3015\u20133029. https:\/\/doi.org\/10.1084\/jem.20090847","journal-title":"J Exp Med"},{"key":"4047_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","volume":"34","author":"SH Baumeister","year":"2016","unstructured":"Baumeister SH, Freeman GJ, Dranoff G, Sharpe AH (2016) Coinhibitory pathways in immunotherapy for cancer. Annu Rev Immunol 34:539\u2013573. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112049","journal-title":"Annu Rev Immunol"},{"key":"4047_CR13","doi-asserted-by":"publisher","unstructured":"Green MR, Monti S, Rodig SJ et al (2010) Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosis Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 116(17):3268\u20133277. https:\/\/doi.org\/10.1182\/blood-2010-05-282780","DOI":"10.1182\/blood-2010-05-282780"},{"issue":"23","key":"4047_CR14","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","volume":"34","author":"MG Roemer","year":"2016","unstructured":"Roemer MG, Advani RH, Ligon AH et al (2016) PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol 34(23):2690\u20132697. https:\/\/doi.org\/10.1200\/JCO.2016.66.4482","journal-title":"J Clin Oncol"},{"issue":"3","key":"4047_CR15","first-page":"549","volume":"60","author":"S Joos","year":"2000","unstructured":"Joos S, Kupper M, Ohl S et al (2000) Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res 60(3):549\u2013552.","journal-title":"Cancer Res"},{"issue":"6","key":"4047_CR16","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","volume":"18","author":"MR Green","year":"2012","unstructured":"Green MR, Rodig S, Juszczynski P et al (2012) Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and post-transplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res 18(6):1611\u20131618. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1942","journal-title":"Clin Cancer Res"},{"issue":"13","key":"4047_CR17","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","volume":"19","author":"BJ Chen","year":"2013","unstructured":"Chen BJ, Chapuy B, Ouyang J et al (2013) PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clin Cancer Res 19(13):3462\u20133473. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0855","journal-title":"Clin Cancer Res"},{"key":"4047_CR18","doi-asserted-by":"publisher","unstructured":"Roemer MG, Advani RH, Redd R et al (2016) Classical Hodgkin lymphoma with reduced b2M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status. Cancer Immunol Res 4(11):910\u2013916. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0201","DOI":"10.1158\/2326-6066.CIR-16-0201"},{"issue":"4","key":"4047_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00428-018-2438-6","volume":"474","author":"T Menter","year":"2019","unstructured":"Menter T, Tzankov A (2019) Genetic alterations of 9p24 in lymphomas and their impact for cancer (immuno-) therapy. Virchows Arch 474(4):497\u2013509. https:\/\/doi.org\/10.1007\/s00428-018-2438-6","journal-title":"Virchows Arch"},{"key":"4047_CR20","doi-asserted-by":"publisher","unstructured":"Gerhard-Hartmann E, Goergen H, Br\u00f6ckelmann PJ et al (2022) 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial. Br J Haematol 196(1):116\u2013126. https:\/\/doi.org\/10.1111\/bjh.17793","DOI":"10.1111\/bjh.17793"},{"key":"4047_CR21","doi-asserted-by":"publisher","unstructured":"Kirill L, Nikolaeva E, Kuznetsov Y et al (2021) The prognostic value of PD-L1 and PD-L2 loci alterations in patients with relapsed\/refractory Hodgkin lymphoma treated with nivolumab. Presented at: 26th Congress of the European Hematology Association, June 9\u201317, 2021. HemaSphere 5(S2): 357. Abstract EP781. https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/https:\/\/doi.org\/10.1097\/HS9.0000000000000566","DOI":"10.1097\/HS9.0000000000000566"},{"issue":"5","key":"4047_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/bjh.15838","volume":"185","author":"A Pavlovsky","year":"2019","unstructured":"Pavlovsky A, Fernandez I, Kurgansky N et al (2019) PET-adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH-05 trial. Br J Haematol 185(5):865\u2013873. https:\/\/doi.org\/10.1111\/bjh.15838","journal-title":"Br J Haematol"},{"issue":"5","key":"4047_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/gcc.22345","volume":"55","author":"K Van Roosbroeck","year":"2016","unstructured":"Van Roosbroeck K, Ferreiro JF, Tousseyn T et al (2016) Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies. Genes Chrom Cancer 55(5):428\u2013441. https:\/\/doi.org\/10.1002\/gcc.22345","journal-title":"Genes Chrom Cancer"},{"issue":"23","key":"4047_CR24","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1200\/JCO.19.00315","volume":"37","author":"R Ramchandren","year":"2019","unstructured":"Ramchandren R, Domingo-Domenech E, Rueda A et al (2019) Nivolumab for newly diagnosed advanced-stage classic Hodgkin lymphoma: safety and efficacy in the phase II Check Mate 205 Study. J Clin Oncol 37(23):1997\u20132007. https:\/\/doi.org\/10.1200\/JCO.19.00315","journal-title":"J Clin Oncol"},{"issue":"10","key":"4047_CR25","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","volume":"36","author":"MG Roemer","year":"2018","unstructured":"Roemer MG, Redd RA, Cader FZ et al (2018) Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma. J Clin Oncol 36(10):942\u2013950. https:\/\/doi.org\/10.1200\/JCO.2017.77.3994","journal-title":"J Clin Oncol"},{"key":"4047_CR26","doi-asserted-by":"publisher","unstructured":"Ohsawa K, Momose S, Nishikori A et al (2024) Copy number analysis of 9p24.1 in classic Hodgkin lymphoma arising in immune deficiency\/dysregulation. Cancers (Basel) 27;16(7):1298. https:\/\/doi.org\/10.3390\/cancers16071298","DOI":"10.3390\/cancers16071298"},{"issue":"17","key":"4047_CR27","doi-asserted-by":"publisher","first-page":"13187","DOI":"10.3390\/ijms241713187","volume":"24","author":"TP Vassilakopoulos","year":"2023","unstructured":"Vassilakopoulos TP, Liaskas A, Pereyra P et al (2023) (2023) Incorporating monoclonal antibodies into the first-line treatment of classical Hodgkin lymphoma. Int J Mol Sci 24(17):13187. https:\/\/doi.org\/10.3390\/ijms241713187","journal-title":"Int J Mol Sci"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04047-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04047-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04047-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T03:08:50Z","timestamp":1747796930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04047-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4047"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04047-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committees of each Institution, and it is in accordance with the current version of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided their written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}